Fig. 2From: Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trialGlycosylated hemoglobin, HbA1c (%) changes from baseline to 12 weeks and 24 weeks in FDC of MSP vs. MS groupBack to article page